The psychopharmacology of brain vascular disease/poststroke depression

Akoudad, 2016, Antidepressant use is associated with an increased risk of developing microbleeds, Stroke, 47, 251, 10.1161/STROKEAHA.115.011574 An, 2017, Effect of transcranial direct current stimulation of stroke patients on depression and quality of life, J Phys Ther Sci, 29, 505, 10.1589/jpts.29.505 Andersen, 1994, Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram, Stroke, 25, 1099, 10.1161/01.STR.25.6.1099 Andrade, 2016, Serotonin reuptake inhibitors and risk of abnormal bleeding, Psychiatr Clin North Am, 39, 413, 10.1016/j.psc.2016.04.010 Ayerbe, 2013, Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis, Br J Psychiatry, 202, 14, 10.1192/bjp.bp.111.107664 Aziz, 2006, Treatments for late-life bipolar disorder, Am J Geriatr Pharmacother, 4, 347, 10.1016/j.amjopharm.2006.12.007 Bartoli, 2017, Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis, J Neurol Neurosurg Psychiatry, 88, 498, 10.1136/jnnp-2017-315660 Benjamin, 2017, Heart disease and stroke statistics—2017 update: a report from the American Heart Association, Circulation, 135, e146, 10.1161/CIR.0000000000000485 Bivard, 2017, MIDAS (modafinil in debilitating fatigue after stroke): a randomized, double-blind, placebo-controlled, cross-over trial, Stroke, 48, 1293, 10.1161/STROKEAHA.116.016293 Brunoni, 2011, Therapeutic interventions for vascular depression: a systematic review, Rev Bras Psiquiatr, 33, 400, 10.1590/S1516-44462011000400015 Canevelli, 2017, Need to recalibrate research outcomes in Alzheimer's disease: focus on neuropsychiatric symptoms, J Am Geriatr Soc, 65, 2071, 10.1111/jgs.14989 Cappelen-Smith, 2017, Reversible cerebral vasoconstriction syndrome: recognition and treatment, Curr Treat Options Neurol, 19, 21, 10.1007/s11940-017-0460-7 Carriere, 2017, Antidepressant use and cognitive decline in community-dwelling elderly people—the Three-City Cohort, BMC Med, 15, 81, 10.1186/s12916-017-0847-z Carson, 2000, Depression after stroke and lesion location: a systematic review, Lancet, 356, 122, 10.1016/S0140-6736(00)02448-X Carvalho, 2016, The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature, Psychother Psychosom, 85, 270, 10.1159/000447034 Choi-Kwon, 2006, Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study, Stroke, 37, 156, 10.1161/01.STR.0000190892.93663.e2 Chollet, 2011, Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial, Lancet Neurol, 10, 123, 10.1016/S1474-4422(10)70314-8 Clayton, 2016, Sexual dysfunction due to psychotropic medications, Psychiatr Clin North Am, 39, 427, 10.1016/j.psc.2016.04.006 Cramer, 2015, Drugs to enhance motor recovery after stroke, Stroke, 46, 2998, 10.1161/STROKEAHA.115.007433 Culebras, 2015, Sleep apnea and stroke, Curr Neurol Neurosci Rep, 15, 503, 10.1007/s11910-014-0503-3 Cumming, 2010, Little evidence for different phenomenology in poststroke depression, Acta Psychiatr Scand, 121, 424, 10.1111/j.1600-0447.2010.01558.x De Ryck, 2014, Risk factors for poststroke depression: identification of inconsistencies based on a systematic review, J Geriatr Psychiatry Neurol, 27, 147, 10.1177/0891988714527514 Delbari, 2011, Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial, Eur Neurol, 66, 7, 10.1159/000329275 Fava, 2016, Antidepressants, 489 Ferro, 2016, Neuropsychiatric sequelae of stroke, Nat Rev Neurol, 12, 269, 10.1038/nrneurol.2016.46 FOCUS Trial Collaboration, 2019, Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial, Lancet, 393, 265, 10.1016/S0140-6736(18)32823-X Fruehwald, 2003, Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow up, J Neurol, 250, 347, 10.1007/s00415-003-1014-3 Funk, 2013, A comparison of the risk of QT prolongation among SSRIs, Ann Pharmacother, 47, 1330, 10.1177/1060028013501994 Grade, 1998, Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study, Arch Phys Med Rehabil, 79, 1047, 10.1016/S0003-9993(98)90169-1 Gustavson, 2016, Problem-solving therapy reduces suicidal ideation in depressed older adults with executive dysfunction, Am J Geriatr Psychiatry, 24, 11, 10.1016/j.jagp.2015.07.010 Hackam, 2012, Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis, Neurology, 79, 1862, 10.1212/WNL.0b013e318271f848 Hackett, 2008, Interventions for treating depression after stroke, Cochrane Database Syst Rev, 4 Hackett, 2014, Neuropsychiatric outcomes of stroke, Lancet Neurol, 13, 525, 10.1016/S1474-4422(14)70016-X Harmer, 2017, How do antidepressants work? New perspectives for refining future treatment approaches, Lancet Psychiatry, 4, 409, 10.1016/S2215-0366(17)30015-9 Jiang, 2015, Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 13, 42, 10.1016/j.cgh.2014.06.021 Jorge, 2011, Treatment of late-life depression: a role of non-invasive brain stimulation techniques, Int Rev Psychiatry, 23, 437, 10.3109/09540261.2011.633501 Jorge, 2003, Mortality and poststroke depression: a placebo-controlled trial of antidepressants, Am J Psychiatry, 160, 1823, 10.1176/appi.ajp.160.10.1823 Jorge, 2008, Treatment of vascular depression using repetitive transcranial magnetic stimulation, Arch Gen Psychiatry, 65, 268, 10.1001/archgenpsychiatry.2007.45 Jorge, 2010, Escitalopram and enhancement of cognitive recovery following stroke, Arch Gen Psychiatry, 67, 187, 10.1001/archgenpsychiatry.2009.185 Kanner, 2016, Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: a review of the evidence, Epilepsy Behav, 61, 282, 10.1016/j.yebeh.2016.03.022 Karaiskos, 2012, Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue, J Neuropsychiatry Clin Neurosci, 24, 349, 10.1176/appi.neuropsych.11110325 Kernan, 2014, Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association, Stroke, 45, 2160, 10.1161/STR.0000000000000024 Kim, 2016, Post-stroke mood and emotional disturbances: pharmacological therapy based on mechanisms, J Stroke, 18, 244, 10.5853/jos.2016.01144 Kim, 2017, Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study, Lancet Psychiatry, 4, 33, 10.1016/S2215-0366(16)30417-5 Koivunen, 2015, Depression, anxiety, and cognitive functioning after intracerebral hemorrhage, Acta Neurol Scand, 132, 179, 10.1111/ane.12367 Kucukalic, 2007, Venlafaxine efficacy and tolerability in the treatment of post-stroke depression, Psychiatr Danub, 19, 56 Kutlubaev, 2014, Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies, Int J Stroke, 9, 1026, 10.1111/ijs.12356 Lipsey, 1984, Nortriptyline treatment of post-stroke depression: a double-blind study, Lancet, 1, 297, 10.1016/S0140-6736(84)90356-8 Marcum, 2016, Antidepressant use and recurrent falls in community-dwelling older adults: findings from the health ABC study, Ann Pharmacother, 50, 525, 10.1177/1060028016644466 Marquez-Romero, 2013, Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial, Trials, 14, 77, 10.1186/1745-6215-14-77 McIntyre, 2016, Repetitive transcranial magnetic stimulation for depression due to cerebrovascular disease: a systematic review, J Stroke Cerebrovasc Dis, 25, 2792, 10.1016/j.jstrokecerebrovasdis.2016.08.043 Mead, 2012, Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery, Cochrane Database Syst Rev, 11 Mead, 2015, The focus, affinity and effects trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials, Trials, 16, 369, 10.1186/s13063-015-0864-1 Mikami, 2011, Effect of antidepressants on the course of disability following stroke, Am J Geriatr Psychiatry, 19, 1007, 10.1097/JGP.0b013e31821181b0 Mitchell, 2013, Attitudinal prosody: what we know and directions for future study, Neurosci Biobehav Rev, 37, 471, 10.1016/j.neubiorev.2013.01.027 Mortensen, 2015, Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients, Expert Opin Drug Saf, 14, 911, 10.1517/14740338.2015.1033396 Mortensen, 2013, Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study, Stroke, 44, 420, 10.1161/STROKEAHA.112.674242 Murray, 2005, Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression, J Clin Psychiatry, 66, 708, 10.4088/JCP.v66n0606 Niedermaier, 2004, Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke, J Clin Psychiatry, 65, 1619, 10.4088/JCP.v65n1206 Pompili, 2015, Suicide in stroke survivors: epidemiology and prevention, Drugs Aging, 32, 21, 10.1007/s40266-014-0233-x Posner, 2011, The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults, Am J Psychiatry, 168, 1266, 10.1176/appi.ajp.2011.10111704 Prince, 2016, Pharmacotherapy of attention-deficit/hyperactivity disorder across the life span, 538 Raffaele, 1996, Trazodone therapy of the post-stroke depression, Arch Gerontol Geriatr, 22, 217, 10.1016/0167-4943(96)86939-1 Ramasubbu, 2004, Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review, J Clin Psychiatry, 65, 1642, 10.4088/JCP.v65n1209 Rampello, 2005, An evaluation of efficacy and safety of reboxetine in elderly patients affected by “retarded” post-stroke depression. A random, placebo-controlled study, Arch Gerontol Geriatr, 40, 275, 10.1016/j.archger.2004.09.004 Reding, 1986, Antidepressant therapy after stroke. A double-blind trial, Arch Neurol, 43, 763, 10.1001/archneur.1986.00520080011011 Robinson, 2016, Post-stroke depression: a review, Am J Psychiatry, 173, 221, 10.1176/appi.ajp.2015.15030363 Robinson, 2000, Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study, Am J Psychiatry, 157, 351, 10.1176/appi.ajp.157.3.351 Robinson, 2008, Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial, JAMA, 299, 2391, 10.1001/jama.299.20.2391 Sadock, 2015 Salter, 2013, Prevention of poststroke depression: does prophylactic pharmacotherapy work?, J Stroke Cerebrovasc Dis, 22, 1243, 10.1016/j.jstrokecerebrovasdis.2012.03.013 Sandberg, 2001, Sleep apnea, delirium, depressed mood, cognition, and ADL ability after stroke, J Am Geriatr Soc, 49, 391, 10.1046/j.1532-5415.2001.49081.x Savadi Oskouie, 2017, Efficacy of citalopram on acute ischemic stroke outcome: a randomized clinical trial, Neurorehabil Neural Repair, 31, 638, 10.1177/1545968317704902 Schambra, 2015, Should this patient with ischemic stroke receive fluoxetine?, PM R, 7, 1294, 10.1016/j.pmrj.2015.11.007 Sibolt, 2013, Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke, Cerebrovasc Dis, 36, 336, 10.1159/000355145 Spalletta, 2006, Response of emotional unawareness after stroke to antidepressant treatment, Am J Geriatr Psychiatry, 14, 220, 10.1097/01.JGP.0000194647.72654.a1 Towfighi, 2017, Poststroke depression: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 48, e30, 10.1161/STR.0000000000000113 Tripp, 2010, Bupropion, a brief history of seizure risk, Gen Hosp Psychiatry, 32, 216, 10.1016/j.genhosppsych.2009.11.004 van Dijk, 2016, Identifying depression post-stroke in patients with aphasia: a systematic review of the reliability, validity and feasibility of available instruments, Clin Rehabil, 30, 795, 10.1177/0269215515599665 Vieta, 2013, Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis, CNS Drugs, 27, 515, 10.1007/s40263-013-0073-y Warden, 2016, Do selective serotonin reuptake inhibitors (SSRIs) cause fractures?, Curr Osteoporos Rep, 14, 211, 10.1007/s11914-016-0322-3 Wiart, 2000, Fluoxetine in early poststroke depression: a double-blind placebo-controlled study, Stroke, 31, 1829, 10.1161/01.STR.31.8.1829 Wortzel, 2008, Pathological laughing and crying: epidemiology, pathophysiology and treatment, CNS Drugs, 22, 531, 10.2165/00023210-200822070-00001 Xu, 2016, Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression, Medicine (Baltimore), 95, 10.1097/MD.0000000000005349 Young, 2016, SSRI/SNRI use is not associated with increased risk of delayed cerebral ischemia after aSAH, Neurocrit Care, 24, 197, 10.1007/s12028-015-0190-1 Zhang, 2013, Prophylactic effects of duloxetine on post-stroke depression symptoms: an open single-blind trial, Eur Neurol, 69, 336, 10.1159/000345374 Columbia-Suicide Severity Rating Scale Screen Version-Recent. 2008, http://cssrs.columbia.edu/documents/clinical-practice-screener-recent/. Last accessed April 8, 2019.